Nomic: Funding, Investors & Team (Sep 2026)
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology. NPlex's platform and research provides cost-effective measurement of protein data with sample, fits seamlessly within industry cytometers for high-throughput analysis, and development of custom protein panels. It allows nanotechnology developers and businesses to bring improvement in existing instrument, workflow, and bring automation in the system.
Nomic has raised $59.0M across 2 funding rounds on record, the most recent a Series B of $42.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nomic Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Nomic Funding Rounds
Nomic raised $17.0M in a Series A announced in Dec 2021.
2.8 years later, a Series B of $42.0M was announced in Sep 2024.
Nomic Founders and Leadership Team
No contact details are on record for this team yet.
Nomic Funding Compared to Other Biotechnology Startups
Nomic's latest round of $42.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nomic in Biotechnology and Montréal
Companies Similar to Nomic
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Nomic Funding FAQs
What does Nomic do?
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology. NPlex's platform and research provides cost-effective measurement of protein data with sample, fits seamlessly within industry cytometers for high-throughput analysis, and development of custom protein panels. It allows nanotechnology developers and businesses to bring improvement in existing instrument, workflow, and bring automation in the system.
How much funding has Nomic raised?
Nomic has raised $59.0M across 2 rounds on record. The most recent is a Series B of $42.0M announced in Sep 2024.
When did Nomic last raise funding?
Nomic's most recent funding round on record is a Series B of $42.0M, announced in Sep 2024.
Who founded Nomic?
FundedIQ lists Jeff Munzar (Founder) at Nomic.
Who is the CEO of Nomic?
Milad Dagher is listed as CEO at Nomic.
Where is Nomic headquartered?
Nomic is based in Montréal, Quebec, Canada.
How many employees does Nomic have?
Nomic is in the 11-50 employee band.
How does Nomic's funding compare to other Biotechnology startups?
Nomic's latest round of $42.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Nomic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nomic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.